TIMP2 is a Poor Prognostic Factor and Predicts Metastatic Biological Behavior in Gastric Cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TIMP2 is a Poor Prognostic Factor and Predicts Metastatic Biological Behavior in Gastric Cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-06-19
DOI
10.1038/s41598-018-27897-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma
- (2017) Timothy A. Dinh et al. Scientific Reports
- Host immune response index in gastric cancer identified by comprehensive analyses of tumor immunity
- (2017) Charny Park et al. OncoImmunology
- Expression of matrix metalloproteinase-2 and its tissue inhibitor-2 in fetal and neoplastic thyroid tissue and their significance as diagnostic and prognostic markers in papillary carcinoma
- (2017) Ilona Mareĉko et al. Cancer Biomarkers
- Identification of a prognostic 5-Gene expression signature for gastric cancer
- (2016) Jun-Yi Hou et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- May High MMP-2 and TIMP-2 Expressions Increase or Decrease the Aggressivity of Oral Cancer?
- (2016) Bijayatha Shrestha et al. PATHOLOGY & ONCOLOGY RESEARCH
- Notch1 pathway-mediated microRNA-151-5p promotes gastric cancer progression
- (2016) Kai-Wen Hsu et al. Oncotarget
- miR-4443 Participates in the Malignancy of Breast Cancer
- (2016) Xiu Chen et al. PLoS One
- TIMP-2 gene methylation in cervical precursor and invasive lesions
- (2015) Yara Furtado et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-2: Prognostic biological markers in invasive prolactinomas
- (2015) Güliz Demirelli Gültekin et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
- (2015) Razvan Cristescu et al. NATURE MEDICINE
- Prognostic Value of Tissue Inhibitor of Metalloproteinase-2 Expression in Patients with Non–Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
- (2015) Lin Zhu et al. PLoS One
- Matrix metalloproteinase 2 (MMP-2) and their tissue inhibitor 2 (TIMP-2) in gastric cancer patients
- (2014) M Łukaszewicz-Zając et al. Advances in Medical Sciences
- Serum levels and tissue expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases 2 (TIMP-2) in colorectal cancer patients
- (2014) Magdalena Groblewska et al. TUMOR BIOLOGY
- Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary cervical cancer: Results of a companion protocol of the randomized, NOGGO–AGO phase III adjuvant trial of simultaneous cisplatin-based radiochemotherapy vs. carboplatin and paclitaxel containing sequential radiotherapy
- (2013) E.I. Braicu et al. CYTOKINE
- Clinical significance of serum levels of matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor (TIMP-2) in gastric cancer
- (2013) Barbara Mroczko et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival
- (2013) Ferhat Ozden et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Enhanced Immunoreactivity of TIMP-2 in the Stromal Compartment of Tumor as a Marker of Favorable Prognosis in Ovarian Cancer Patients
- (2012) Agnieszka Hałoń et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Immunoreactivity for TIMP-2 is associated with a favorable prognosis in endometrial carcinoma
- (2012) Maria Honkavuori-Toivola et al. TUMOR BIOLOGY
- Molecular Classification of Gastric Cancer: A New Paradigm
- (2011) M. A. Shah et al. CLINICAL CANCER RESEARCH
- Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: A survival study
- (2011) Andreia Santos et al. VETERINARY JOURNAL
- Increased matrix metalloproteinases 2 and 9 and tissue inhibitor of matrix metalloproteinase 2 expression is associated with progression from vulvar intraepithelial neoplasia to invasive carcinoma
- (2010) Milla Määttä et al. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
- 7th Edition of the AJCC Cancer Staging Manual: Stomach
- (2010) Kay Washington ANNALS OF SURGICAL ONCOLOGY
- Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer
- (2010) Kyung Sook Park et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells
- (2010) Chunling Wang et al. LEUKEMIA RESEARCH
- Clinical Impact of MMP and TIMP Gene Polymorphisms in Gastric Cancer
- (2010) Hakan Alakus et al. WORLD JOURNAL OF SURGERY
- Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy
- (2009) Alex Y. Strongin BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Low Circulating Levels of ProMMP-2 Are Associated with Adverse Prognosis in Bladder Cancer
- (2008) Kaija Vasala et al. TUMOR BIOLOGY
- Key Issues in Conducting a Meta-Analysis of Gene Expression Microarray Datasets
- (2008) Adaikalavan Ramasamy et al. PLOS MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started